FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4365511846> ?p ?o ?g. }

• W4365511846 endingPage "LB095" @default.
• W4365511846 startingPage "LB095" @default.
• W4365511846 abstract "Abstract Mutation-associated neoantigens (MANAs) are exquisitely cancer-specific therapeutic targets. However, MANAs are present at ultra-low densities on the cancer cell surface (as few as 1-2 copies per cell), leading to the challenge of eliciting a sufficiently robust therapeutic effect. We combined components of both T cell receptors (TCRs) and chimeric antigen receptors (CARs) to create a new receptor with improved potency against an ultra-low-density MANA. From CARs, we utilized the antibody-based antigen recognition domain (i.e. the single chain variable fragment, scFv) and the integrated co-stimulation that amplifies T cell activation. From TCRs, we utilized the multi-chain signaling platform that facilitates high antigen sensitivity. This new receptor, termed a TCR Embedded ScFv for Long-term Activation (TESLA), showed promising characteristics when tested with the H2-scFv which targets the p53 R175H mutation presented on HLA-A*02:01 (R175H/A2). Using CRISPR-based homology directed repair in primary human T cells, we tested 15 configurations of appending the H2-scFv to subunits of the TCR complex to identify a design that maximized T cell cytotoxicity and interferon gamma release in co-cultures with cancer cells expressing endogenous levels of the R175H/A2 antigen. In this system, we showed that the optimal TCR-embedded configuration of the H2-scFv produced similar levels of cytotoxicity and interferon gamma secretion as patient-derived TCRs targeting the same R175H/A2 MANA, while conventional H2-CARs were unable to produce any T-cell activation. We then used a multiple stimulation co-culture system to identify a co-stimulation domain combination (MyD88 and CD40) that improved serial cytotoxicity and proliferation of H2-TESLAs when incorporated on the intracellular side of the TCRbeta chain. Finally, we compared the H2-TESLA receptor to patient-derived TCRs modified with the same MyD88 and CD40 co-stimulation domains. In vivo, H2-TESLAs cured all mice in a tumor model, while co-stimulation-modified TCRs produced only temporary tumor control. Moreover, in vivo, H2-TESLAs elicited 100-fold greater T cell expansion than co-stimulation-modified TCRs. In conclusion, we demonstrated that by combining aspects of both CARs and TCRs, the TESLA receptor improved T cell reactivity against an ultra-low-density neoantigen compared to conventional CARs and patient-derived TCRs. Citation Format: Brian J. Mog, Sarah R. DiNapoli, Michael S. Hwang, Tushar D. Nichakawade, Jacqueline Douglass, Emily Han-Chung Hsiue, Katharine M. Wright, Alexander H. Pearlman, Maximilian F. Konig, Suman Paul, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Jiaxin Ge, Michelle S. Miller, P. Aitana Azurmendi, Evangeline Watson, Drew M. Pardoll, Sandra B. Gabelli, Chetan Bettegowda, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Shibin Zhou. Hybrid TCR-CAR design surpasses conventional CARs and patient-derived TCRs in targeting an ultra-low-density neoantigen [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 2 (Clinical Trials and Late-Breaking Research); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(8_Suppl):Abstract nr LB095." @default.
• W4365511846 created "2023-04-15" @default.
• W4365511846 creator A5000152049 @default.
• W4365511846 creator A5001934439 @default.
• W4365511846 creator A5003078987 @default.
• W4365511846 creator A5008764156 @default.
• W4365511846 creator A5016013383 @default.
• W4365511846 creator A5024621602 @default.
• W4365511846 creator A5034530447 @default.
• W4365511846 creator A5037021577 @default.
• W4365511846 creator A5048442212 @default.
• W4365511846 creator A5050255793 @default.
• W4365511846 creator A5050727908 @default.
• W4365511846 creator A5051536376 @default.
• W4365511846 creator A5059462255 @default.
• W4365511846 creator A5066066900 @default.
• W4365511846 creator A5066707073 @default.
• W4365511846 creator A5067086182 @default.
• W4365511846 creator A5067934290 @default.
• W4365511846 creator A5068730927 @default.
• W4365511846 creator A5069558252 @default.
• W4365511846 creator A5072858943 @default.
• W4365511846 creator A5077581858 @default.
• W4365511846 creator A5081241879 @default.
• W4365511846 creator A5083042437 @default.
• W4365511846 creator A5090480629 @default.
• W4365511846 date "2023-04-14" @default.
• W4365511846 modified "2023-10-16" @default.
• W4365511846 title "Abstract LB095: Hybrid TCR-CAR design surpasses conventional CARs and patient-derived TCRs in targeting an ultra-low-density neoantigen" @default.
• W4365511846 doi "https://doi.org/10.1158/1538-7445.am2023-lb095" @default.
• W4365511846 hasPublicationYear "2023" @default.
• W4365511846 type Work @default.
• W4365511846 citedByCount "0" @default.
• W4365511846 crossrefType "journal-article" @default.
• W4365511846 hasAuthorship W4365511846A5000152049 @default.
• W4365511846 hasAuthorship W4365511846A5001934439 @default.
• W4365511846 hasAuthorship W4365511846A5003078987 @default.
• W4365511846 hasAuthorship W4365511846A5008764156 @default.
• W4365511846 hasAuthorship W4365511846A5016013383 @default.
• W4365511846 hasAuthorship W4365511846A5024621602 @default.
• W4365511846 hasAuthorship W4365511846A5034530447 @default.
• W4365511846 hasAuthorship W4365511846A5037021577 @default.
• W4365511846 hasAuthorship W4365511846A5048442212 @default.
• W4365511846 hasAuthorship W4365511846A5050255793 @default.
• W4365511846 hasAuthorship W4365511846A5050727908 @default.
• W4365511846 hasAuthorship W4365511846A5051536376 @default.
• W4365511846 hasAuthorship W4365511846A5059462255 @default.
• W4365511846 hasAuthorship W4365511846A5066066900 @default.
• W4365511846 hasAuthorship W4365511846A5066707073 @default.
• W4365511846 hasAuthorship W4365511846A5067086182 @default.
• W4365511846 hasAuthorship W4365511846A5067934290 @default.
• W4365511846 hasAuthorship W4365511846A5068730927 @default.
• W4365511846 hasAuthorship W4365511846A5069558252 @default.
• W4365511846 hasAuthorship W4365511846A5072858943 @default.
• W4365511846 hasAuthorship W4365511846A5077581858 @default.
• W4365511846 hasAuthorship W4365511846A5081241879 @default.
• W4365511846 hasAuthorship W4365511846A5083042437 @default.
• W4365511846 hasAuthorship W4365511846A5090480629 @default.
• W4365511846 hasConcept C109316439 @default.
• W4365511846 hasConcept C147483822 @default.
• W4365511846 hasConcept C153911025 @default.
• W4365511846 hasConcept C159654299 @default.
• W4365511846 hasConcept C170493617 @default.
• W4365511846 hasConcept C19317047 @default.
• W4365511846 hasConcept C202751555 @default.
• W4365511846 hasConcept C203014093 @default.
• W4365511846 hasConcept C2776090121 @default.
• W4365511846 hasConcept C3875195 @default.
• W4365511846 hasConcept C54355233 @default.
• W4365511846 hasConcept C86803240 @default.
• W4365511846 hasConcept C8891405 @default.
• W4365511846 hasConcept C95444343 @default.
• W4365511846 hasConceptScore W4365511846C109316439 @default.
• W4365511846 hasConceptScore W4365511846C147483822 @default.
• W4365511846 hasConceptScore W4365511846C153911025 @default.
• W4365511846 hasConceptScore W4365511846C159654299 @default.
• W4365511846 hasConceptScore W4365511846C170493617 @default.
• W4365511846 hasConceptScore W4365511846C19317047 @default.
• W4365511846 hasConceptScore W4365511846C202751555 @default.
• W4365511846 hasConceptScore W4365511846C203014093 @default.
• W4365511846 hasConceptScore W4365511846C2776090121 @default.
• W4365511846 hasConceptScore W4365511846C3875195 @default.
• W4365511846 hasConceptScore W4365511846C54355233 @default.
• W4365511846 hasConceptScore W4365511846C86803240 @default.
• W4365511846 hasConceptScore W4365511846C8891405 @default.
• W4365511846 hasConceptScore W4365511846C95444343 @default.
• W4365511846 hasIssue "8_Supplement" @default.
• W4365511846 hasLocation W43655118461 @default.
• W4365511846 hasOpenAccess W4365511846 @default.
• W4365511846 hasPrimaryLocation W43655118461 @default.
• W4365511846 hasRelatedWork W1613939252 @default.
• W4365511846 hasRelatedWork W1973692620 @default.
• W4365511846 hasRelatedWork W2747317233 @default.
• W4365511846 hasRelatedWork W2972102845 @default.
• W4365511846 hasRelatedWork W3003314604 @default.
• W4365511846 hasRelatedWork W3010699190 @default.
• W4365511846 hasRelatedWork W3040292335 @default.
• W4365511846 hasRelatedWork W3094872615 @default.

• next